The Department of War's (DoW) Joint Project Manager (JPM) for CBRN Medical is seeking information on devices capable of delivering nalmefene via both inhalation and intramuscular routes of administration for both prophylactic and therapeutic purposes. The device must be ruggedized and compliant with military standards, and designed to meet FDA approval requirements as both a therapeutic and prophylactic product and a medical device. Respondents are asked to provide white papers, concept briefs, and technical insights on their system's capability, including design feasibility, integration paths, operational readiness, and sustainment strategies. • The device must be capable of delivering nalmefene via both inhalation and intramuscular routes. • The device must be ruggedized and compliant with military standards. • The device must be designed to meet FDA approval requirements as both a therapeutic and prophylactic product and a medical device. • Respondents must provide white papers, concept briefs, and technical insights on their system's capability. • Submissions should be no more than five pages, with past performances limited to one page.